PRINCETON, N.J., Sept 1 (Bernama-GLOBE NEWSWIRE) — Indegene, a technology-led healthcare solutions provider, today announced the acquisition of Medical Marketing Economics, LLC (MME), a global leader in Pricing, Reimbursement and Market Access (PRMA) services.
Life sciences organizations especially emerging Biotech companies offering solutions in rare diseases, increasingly struggle with determining and communicating the optimal market value of their innovations. MME offers pricing and reimbursement, contracting strategy and tactics, and custom payer market research to address these challenges. MME’s team brings in a cumulative 300 years of pharma market access, pricing and reimbursement experience and its senior executives have had to make the same decisions as their clients in prior roles.